NCT06645509 is a Phase 2 clinical trial of TTB gel (dose 1) in Palmar Hyperhidrosis, sponsored by Dryox Health.

Who is sponsoring NCT06645509?

NCT06645509 is sponsored by Dryox Health.

What drugs are being tested in NCT06645509?

Interventions in NCT06645509: TTB gel (dose 1), TTB gel (dose 2), Placebo.

What condition does NCT06645509 study?

NCT06645509 studies Palmar Hyperhidrosis.

Is NCT06645509 still recruiting?

NCT06645509 is currently terminated. Last updated 22 June 2025.

Last reviewed 2025-06-22 · How we verify

NCT06645509

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy

Terminated Phase 2 Last updated 22 June 2025

What this trial tests

Phase 2 trial testing TTB gel (dose 1) in Palmar Hyperhidrosis in 58 participants. Terminated before completion.

Timeline

29 April 2024

Primary endpoint
2 June 2025

2 June 2025

Quick facts

Lead sponsor	Dryox Health
Phase	Phase 2
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	58
Start date	29 April 2024
Primary completion	2 June 2025
Estimated completion	2 June 2025
Sites	4 locations across Spain

Drugs / interventions tested

TTB gel (dose 1) — full drug profile →
TTB gel (dose 2)
Placebo

Conditions studied

Palmar Hyperhidrosis — all drugs for Palmar Hyperhidrosis →

Sponsor

Dryox Health — full company profile →

Who can join

18 and older, any sex, with Palmar Hyperhidrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to assess the efficacy and safety of Victorhy, a topical TTB gel in patients with severe primary hand hyperhidrosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Palmar Hyperhidrosis

Currently open trials in the same condition.

NCT06881394 — A Polymer Film Device to Treat Excessive Palmar Sweating · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06645509 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dryox Health
Last refreshed: 22 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06645509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing